3BBLACKBIOBSE3B BLACKBIO DX LTD.MinimalNeutral
Announced Wed, 30 Sept, 2026 · 16:42 IST

3B BlackBio Dx: All 5 AGM resolutions passed; Rs 5 dividend declared

3BBLACKBIO · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
-1.7%Reaction day
₹1691.50
prior close
₹1690.20
announcement price
After-mkt
timing
Nifty Microcap 250market · in no size index; the smallest one is used-1.3%-0.4% vs market
Healthcare Service Provider peers, median of 27sector-1.1%-0.6% vs sector

On the reaction day the stock moved 0.4 pts less than Nifty Microcap 250 and 0.6 pts less than its Healthcare Service Provider peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
+0.2
10m
-0.2
15m
+0.2
30m
-0.0
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
-1.7-1.3-0.4-1.1-0.6
Next day
-4.8-1.3-3.6-1.7-3.1
2d
-6.2+0.0-6.2-1.6-4.6
3d
-6.1-0.2-5.8-2.2-3.8
4d
-9.5-3.0-6.6-4.3-5.3
5d
-5.6-2.7-2.9-2.6-3.1
1w
-10.3-1.7-8.6-3.6-6.7
15d
-16.6-8.9-7.8-5.3-11.4
1m
—————
2m
—————
3m
—————
UpDownMarket · Nifty Microcap 250Sector · Healthcare Service Provider peers, median of 27Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

At the 54th AGM held on Sep 29, 2026, all 5 resolutions were passed with near-unanimous support. Items include adoption of standalone and consolidated financial statements for FY25-26, declaration of a 50 percent dividend (Rs 5 per equity share), re-appointment of Mrs. Mithla Dubey as director (96.79 percent in favour, passed as special resolution), and ratification of cost auditor remuneration of Rs 50,000. Out of 11,122 shareholders, 53 attended via video conferencing.

Likely market impact

Rs 5 per share dividend confirmed for FY25-26. All resolutions passed with near-unanimous support, reflecting strong shareholder confidence in management.